Remarkably, the loss of ARID1A protein expression in CRC patients was significantly associated with poorly differentiated grade and advanced tumor depth [123], suggesting the loss of ARID1A protein expression as a predictive marker for poor prognosis CRC. The gene discussed is ARID1A; the disease is neoplasm.